Published in Blood on September 29, 2008
Hepcidin and iron regulation, 10 years later. Blood (2011) 3.80
β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood (2011) 1.81
Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. J Cell Physiol (2010) 1.81
Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica (2010) 1.47
Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev (2013) 1.47
Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest (2012) 1.35
Ineffective erythropoiesis and thalassemias. Curr Opin Hematol (2009) 1.34
Towards explaining "unexplained hyperferritinemia". Haematologica (2009) 1.33
Growth differentiation factor 15 in erythroid health and disease. Curr Opin Hematol (2010) 1.21
Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood (2013) 1.21
Iron Loading and Overloading due to Ineffective Erythropoiesis. Adv Hematol (2010) 1.19
Concise review: growth differentiation factor 15 in pathology: a clinical role? Stem Cells Transl Med (2013) 1.11
Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol (2009) 1.09
The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice. Haematologica (2012) 1.08
Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation. Transfusion (2010) 1.01
Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica (2012) 0.99
New insights into iron regulation and erythropoiesis. Curr Opin Hematol (2015) 0.98
Molecular liaisons between erythropoiesis and iron metabolism. Blood (2014) 0.97
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1. Haematologica (2013) 0.96
Iron metabolism in thalassemia and sickle cell disease. Mediterr J Hematol Infect Dis (2009) 0.95
Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II. Haematologica (2009) 0.87
Oxidative stress in β-thalassaemia and sickle cell disease. Redox Biol (2015) 0.84
Ferroportin and erythroid cells: an update. Adv Hematol (2010) 0.81
Interrelationships between tissue iron status and erythropoiesis during postweaning development following neonatal iron deficiency in rats. Am J Physiol Gastrointest Liver Physiol (2010) 0.80
Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions. Leuk Res (2014) 0.80
The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis. Cancer Med (2015) 0.78
Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationship. Haematologica (2010) 0.78
Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia. PLoS One (2017) 0.76
Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model. Haematologica (2016) 0.75
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med (2007) 5.18
Hepcidin is decreased in TFR2 hemochromatosis. Blood (2004) 3.46
Hepcidin in iron overload disorders. Blood (2005) 2.88
Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica (2007) 2.52
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One (2008) 2.13
Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta (1968) 2.02
Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood (2008) 1.88
Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol (2005) 1.62
Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis (2007) 1.51
Hepcidin and iron-loading anemias. Haematologica (2006) 1.49
Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet (2002) 1.32
Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am J Hematol (2007) 1.14
Dyserythropoiesis and congenital dyserythropoietic anaemias. Br J Haematol (1997) 1.11
Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood (1996) 1.08
Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. Br J Haematol (1999) 1.04
Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1). Eur J Haematol (2007) 0.87
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18
Many sequence variants affecting diversity of adult human height. Nat Genet (2008) 12.80
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2007) 10.81
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2008) 7.65
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med (2007) 5.18
NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci U S A (2007) 5.14
Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest (2005) 4.84
DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res (2002) 3.78
Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women. Am J Clin Nutr (2010) 2.80
Hepcidin: from discovery to differential diagnosis. Haematologica (2008) 2.69
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood (2009) 2.65
Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet (2002) 2.63
Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer (2006) 2.50
Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem (2007) 2.41
Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum (2011) 2.38
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis (2011) 2.05
Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest (2003) 2.00
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis (2011) 1.74
Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat (2002) 1.70
Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood. Pediatr Blood Cancer (2011) 1.69
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol (2010) 1.66
Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis (2009) 1.63
Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol (2006) 1.60
The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. Blood (2003) 1.60
CATSPER2, a human autosomal nonsyndromic male infertility gene. Eur J Hum Genet (2003) 1.54
Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis (2007) 1.51
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Hepcidin in human iron disorders: diagnostic implications. Clin Chem (2011) 1.50
Individualized treatment for iron-deficiency anemia in adults. Am J Med (2008) 1.50
Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem (2005) 1.48
Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation. Blood (2002) 1.48
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma (2013) 1.47
Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica (2010) 1.47
Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. J Gerontol A Biol Sci Med Sci (2010) 1.45
Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet (2002) 1.32
(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem (2009) 1.30
The human reticulocyte transcriptome. Physiol Genomics (2007) 1.28
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant (2009) 1.22
Growth differentiation factor 15 in erythroid health and disease. Curr Opin Hematol (2010) 1.21
Iron Loading and Overloading due to Ineffective Erythropoiesis. Adv Hematol (2010) 1.19
A signaling mechanism for growth-related expression of fetal hemoglobin. Blood (2003) 1.19
Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol (2008) 1.19
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes. Haematologica (2010) 1.19
Mutated nup62 causes autosomal recessive infantile bilateral striatal necrosis. Ann Neurol (2006) 1.19
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol (2009) 1.19
Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab (2009) 1.18
A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells. Blood (2004) 1.18
Neurokinin-B transcription in erythroid cells: direct activation by the hematopoietic transcription factor GATA-1. J Biol Chem (2004) 1.17
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. Anal Biochem (2005) 1.16
CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet (2012) 1.16
Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood (2009) 1.15
Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS One (2012) 1.12
Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol (2003) 1.09
Shedding & shaving: disclosure of proteomic expressions on a bacterial face. Proteomics (2008) 1.09
An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One (2008) 1.06
The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis. J Clin Endocrinol Metab (2009) 1.06
A newly discovered human alpha-globin gene. Blood (2005) 1.05
A novel immunological assay for hepcidin quantification in human serum. PLoS One (2009) 1.05
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol (2010) 1.05
Training surface and intensity: inflammation, hemolysis, and hepcidin expression. Med Sci Sports Exerc (2009) 1.04
Fetal hemoglobin silencing in humans. Blood (2006) 1.03
Fetal hemoglobin modulation during human erythropoiesis: stem cell factor has "late" effects related to the expression pattern of CD117. Blood (2002) 1.03
Cumulative effects of consecutive running sessions on hemolysis, inflammation and hepcidin activity. Eur J Appl Physiol (2009) 1.03
Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr (2009) 1.02
Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol (2003) 1.01
Let-7 microRNAs are developmentally regulated in circulating human erythroid cells. J Transl Med (2009) 1.01
Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation. Transfusion (2010) 1.01
Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One (2011) 1.00
LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo. Blood (2013) 1.00
High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion (2012) 1.00
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol (2009) 0.99
The effects of carbohydrate ingestion during endurance running on post-exercise inflammation and hepcidin levels. Eur J Appl Physiol (2011) 0.98
Effects of exercise on hepcidin response and iron metabolism during recovery. Int J Sport Nutr Exerc Metab (2009) 0.98
Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. Eur J Heart Fail (2010) 0.97
Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res (2002) 0.96
Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol (2012) 0.96
Hembase: browser and genome portal for hematology and erythroid biology. Nucleic Acids Res (2004) 0.96
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1. Haematologica (2013) 0.96
Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev (2014) 0.96
Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl) (2011) 0.95
Surface-exposed histone-like protein a modulates adherence of Streptococcus gallolyticus to colon adenocarcinoma cells. Infect Immun (2009) 0.95
Cloning and characterization of a gene expressed during terminal differentiation that encodes a novel inhibitor of growth. J Biol Chem (2003) 0.95
Effect of exercise modality and intensity on post-exercise interleukin-6 and hepcidin levels. Int J Sport Nutr Exerc Metab (2012) 0.94
Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. J Pediatr (2003) 0.94
Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant (2012) 0.93
Effect of the new HJV-L165X mutation on penetrance of HFE. Blood (2007) 0.93
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS One (2012) 0.92
Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers. Hepatology (2013) 0.92
Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. Am J Clin Nutr (2008) 0.92
The effects of acute exercise bouts on hepcidin in women. Int J Sport Nutr Exerc Metab (2012) 0.92